Skip to content

Silo Pharma, Inc.

SILO· NasdaqCore metricsCIK 1514183

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · +4.11%
Market cap
$3.59M
1.89M shares
Filings
382
$18.03K
Q3 2026±0.0% FY25 yoy
-$358.74K
Q3 2026N/M FY25 yoy
-$1.21M
Q3 2026N/M FY25 yoy
—
—
—
-$0.21
Q3 2026N/M FY25 yoy
$6.09M
Q3 2026+21.6% FY25 yoy
$3.59M
—
99.4×
0.4×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$1.90+304.26%+$1.43past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$72.10KFY 2025
$72.10K0FY 2019FY 2020FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$72,102reported
FY 20242024-12-31$72,102reported
FY 20232023-12-31$72,102reported
FY 20222022-12-31$72,102reported
FY 20202020-12-31$40,923reported
FY 20192019-12-31$40,569reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$1.00M$1.00M—2.84M sh−10.0%—

Pharmaceutical preparations

Silo Pharma, Inc. is the 244th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Silo Pharma, Inc. · CIK 1514183 · Engraved from SEC EDGAR